Mojia Biotech Completes Series B Financing To Advance Manufacturing Of Bio-Based Materials
Jun 23, 2022•about 3 years ago
Round Type
series b
Description
Mojia Biotech, a Shanghai-based leading bio-manufacturing company dedicated to sustainable development and carbon neutrality, announced the completion of an $80 million Series B Financing. The funds will be used to commercialize its ViridiminTM brand of animal-feed additives, scale up manufacturing capacity for AliphaneTM series of bio-based materials, advance its product pipeline and expand its global R&D capabilities.